FC
SNY icon

Fusion Capital’s Sanofi SNY Stock Holding History

Fusion Capital’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-151,507
Closed -$7.3M – 116
2026
Q1 		$7.3M Buy
151,507
+7,183
+5% +$335K 1.97% 20
2025
Q4 		$6.99M Buy
144,324
+1,513
+1% +$75K 1.97% 22
2025
Q3 		$7.22M Buy
142,811
+5,824
+4% +$281K 2.1% 20
2025
Q2 		$6.62M Buy
136,987
+5,713
+4% +$292K 2.26% 18
2025
Q1 		$7.28M Sell
131,274
-3,413
-3% -$185K 2.77% 15
2024
Q4 		$6.5M Buy
134,687
+2,110
+2% +$107K 2.62% 15
2024
Q3 		$7.64M Sell
132,577
-1,680
-1% -$90.7K 3.28% 11
2024
Q2 		$6.51M Sell
134,257
-2,890
-2% -$139K 2.97% 14
2024
Q1 		$6.67M Buy
+137,147
New +$6.7M 3.05% 14

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fusion Capital's SNY Position: Q2 2026 in Review

Fusion Capital sold out of Sanofi (SNY) in Q2 2026, closing a stake of 151,507 shares — an estimated $7.3M sold.

Fusion Capital first reported a position in SNY in Q1 2024 and held it in 9 quarters. The position peaked at $7.64M in Q3 2024. 715 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Fusion Capital reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
  • Fusion Capital sold 151,507 Sanofi shares in Q2 2026, an estimated $7.3M.
  • Fusion Capital first reported a position in Sanofi in Q1 2024 and held it in 9 quarters.
  • Fusion Capital's Sanofi position peaked at $7.64M in Q3 2024.
  • 715 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Fusion Capital's 13F filing for Q2 2026, filed 5 Aug 2026.